Drug safety evaluation /
Main Author: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
Hoboken, N.J. :
Wiley,
[2009]
|
Edition: | 2nd ed. |
Series: | Wiley online library.
|
Subjects: | |
Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Front Matter
- Drug Development Process and Global Pharmaceutical Marketplace
- Regulation of Human Pharmaceutical Safety
- Prior Art and Its Use in Safety Assessment Process
- Screens in Safety and Hazard Assessment
- Formulations, Routes, and Dosage Design
- Single-Dose (Acute) and Pilot (DRF) Toxicity Testing in Drug Safety Evaluation
- Genotoxicity
- Repeat-Dose Toxicity Studies
- Immunotoxicology in Drug Development
- Nonrodent Animal Studies
- Developmental and Reproductive Toxicity Testing
- Carcinogenicity Studies
- Histopathology in Nonclinical Pharmaceutical Safety Assessment
- Irritation and Local Tissue Tolerance in Pharmaceutical Safety Assessment
- Pharmacokinetics and Toxicokinetics in Drug Safety Evaluation
- Safety Pharmacology
- Special Concerns for Preclinical Evaluation of Biotechnology Products
- Safety Assessment of Inhalant and Dermal Route Drugs
- Special-Case Products: Imaging Agents and Oncology Drugs
- Occupational Toxicology in Pharmaceutical Industry
- Strategy and Phasing for Nonclinical Drug Safety Evaluation in Discovery and Development of Pharmaceuticals
- Application of In Vitro Techniques in Drug Safety Assessment
- Evaluation of Human Tolerance and Safety in Clinical Trials: FIM Trials and Beyond
- Postmarketing Safety Evaluation: Monitoring, Assessing, and Reporting of Adverse Drug Responses
- Statistics in Pharmaceutical Safety Assessment
- Combination Products: Drugs and Devices
- Qualification of Impurities, Degradants, Residual Solvents, and Leachables in Pharmaceuticals
- Appendix A: Selected Regulatory and Toxicological Acronyms
- Appendix B: Definition of Terms and Lexicon of Clinical Observations in Nonclinical (Animal) Studies
- Appendix C: Notable Regulatory Internet Addresses
- Appendix D: Glossary of Terms Used in Clinical Evaluation of Therapeutic Agents
- Appendix E: Common Vehicles for Nonclinical Evaluation of Therapeutic Agents
- Appendix F: Global Directory of Contract Toxicology Laboratories
- Index.